Financial comparisons Alnylam Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/07/2025 BST			5-day change	1st Jan Change
320.87 ^USD	+1.06%		-0.37%	+36.36%

07-09	Alnylam Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 01, 2025
07-08	Alnylam Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 09:20 AM

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
ALNYLAM PHARMACEUTICALS, INC.	2.25B	-12.37%	-7.87%	-	-6.89%	1.85x
ELI LILLY AND COMPANY	45.04B	23.51%	31.78%	84.84%	14.84%	1.88x
JOHNSON & JOHNSON	88.82B	15.84%	29.8%	34.23%	13.95%	0.36x
ABBVIE INC.	56.33B	7.59%	41.43%	263.08%	13.34%	2.56x
NOVO NORDISK A/S	40.31B	34.78%	44.19%	80.78%	25.88%	0.52x
ROCHE HOLDING AG	66.76B	13.68%	34.42%	43.45%	15.69%	0.74x
NOVARTIS AG	50.32B	23.73%	38.74%	34.74%	15.58%	0.85x
ASTRAZENECA PLC	54.07B	13.01%	31.31%	32.11%	12.51%	1.47x
MERCK & CO., INC.	64.17B	26.68%	36.46%	46.35%	17.38%	0.86x
AMGEN INC.	33.42B	12.24%	44.96%	177.29%	11.36%	2.33x
PFIZER, INC.	63.63B	12.62%	34.24%	19.99%	8.05%	1.52x
GILEAD SCIENCES, INC.	28.75B	1.67%	29.63%	27.6%	9.57%	1.48x
VERTEX PHARMACEUTICALS INCORPORATED	11.02B	-4.86%	6.31%	0.65%	0.49%	-6.77x
SANOFI	42.53B	13.98%	27.61%	11.75%	4.43%	0.68x
BRISTOL-MYERS SQUIBB COMPANY	48.3B	-18.53%	10.77%	10.23%	-9.53%	6.49x
GSK PLC	39.28B	8.21%	29.16%	48.09%	10.97%	1.22x
CHUGAI PHARMACEUTICAL CO., LTD.	7.45B	33.09%	46.3%	22%	18.71%	-1.74x
JIANGSU HENGRUI MEDICINE CO., LTD.	3.83B	22.64%	26.77%	14.73%	13.49%	-2.98x
TAKEDA PHARMACEUTICAL COMPANY LIMITED	30.6B	2.36%	7.48%	1.5%	1.19%	3.6x
Average	40.89B	12.1%	28.61%	52.97%	10.05%	0.89x
Weighted average by Cap.	49.94B	16.31%	32.88%	72.26%	13.19%	1.11x